(2) Prior to receiving treatment at the Facility, the patient shall acknowledge in writing having received education on the following:(a) Treatment options, including detoxification, and the benefits and risks associated with each treatment option;(b) The risk of neonatal abstinence syndrome and use of voluntary long-acting reversible contraception for all female patients of child bearing age and potential;(c) Prevention and treatment of chronic viral illnesses, such as HIV and hepatitis C;(d) Expected therapeutic benefits and adverse effects of treatment medication;(e) Risks for overdose, including drug interactions with CNS depressants, such as alcohol and benzodiazepines, and relapsing after periods of abstinence from opioids; and(f) Overdose prevention and reversal agents.
see full law